ICH Q3D Metal Impurity Risk Assessments Pose Challenges
This article was originally published in The Gold Sheet
Executive Summary
Pharmaceutical manufacturers say there is a lack of clarity in the recently published ICH Q3D guideline on risk assessments for metal impurities, which may potentially complicate implementation.